Drug shortage
Lactated Ringers Injection · B. Braun Medical Inc.
FDA drug shortage · Current · updated Apr 17, 2025
Key facts
| Generic name | Lactated Ringers Injection |
|---|---|
| Proprietary name | Lactated Ringers |
| Company | B. Braun Medical Inc. |
| Presentation | Lactated Ringers, Injection, .02 g/100 mL; .03 g/100 mL; .6 g/100 mL; .31 g/100 mL (NDC 0264-7750-20) |
| Dosage form | Injection |
| Strength | .02 g/100 mL .03 g/100 mL .31 g/100 mL .6 g/100 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Endocrinology/Metabolism Gastroenterology Other |
| Package NDCs | 0264-7750-20 |
| First posted | Oct 11, 2024 |
| Last updated | Apr 17, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: